Site identity card

Hôpital Européen Georges Pompidou

Paris, France
Share

Networks

Clinical Studies (1)

  • Nguyen : Study aims to describe the incidence and outcomes of COVID-19 among immunocompromised patients receiving tixagevimab/cilgavimab as preexposure prophylaxis during the Omicron wave in France

Study Data

  • Adults (18-64 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tixagevimab/Cilgavimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to